守护者健康

最新新闻

• Barclays Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $220
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• Bernstein Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $210
  \u5e02\u573a\u8d44\u8baf · 2026/9/26
• 评级变动
  Barclays Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $200
  \u5e02\u573a\u8d44\u8baf · 2026/9/18
• 公司公告
  HHRG-WB (HHRG BHD): Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - GH CONSORTIUM SDN BHD
  Bursa Malaysia · 2026/2/12
• 评级变动
  Analysts Are Bullish on These Healthcare Stocks: NeurAxis, Inc. (NRXS), Guardant Health (GH)
  TipRanks · 2026/9/16
• 评级变动
  Piper Sandler Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $193
  \u5e02\u573a\u8d44\u8baf · 2026/9/15
• 公司公告
  GH Law Firm (Hangzhou) Legal Opinion on Hangzhou Silan Microelectronics Co., Ltd.'s Fourth Extraordinary General Meeting of Shareholders in 2024.
  SZSI · 2024/6/29
• 评级变动
  William Blair Maintains Guardant Health(GH.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/8
• Goldman Sachs Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $225
  \u5e02\u573a\u8d44\u8baf · 2026/9/21
• 公司公告
  GH Research | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(12.9%),Peter Kolchinsky(12.9%), etc.
  SEC · 2024/11/15
• Guggenheim Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $200
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• BofA Securities Maintains Guardant Health(GH.US) With Buy Rating, Announces Target Price $200
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 公司公告
  HHRG-WB (HHRG BHD): Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - GH CONSORTIUM SDN BHD
  Bursa Malaysia · 2026/1/29
• 评级变动
  Rothschild & Co Redburn Initiates Guardant Health(GH.US) With Buy Rating, Announces Target Price $203
  \u5e02\u573a\u8d44\u8baf · 2026/9/8
• 评级变动
  BTIG Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $195
  \u5e02\u573a\u8d44\u8baf · 2026/9/2
• 评级变动
  Bernstein Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $210
  \u5e02\u573a\u8d44\u8baf · 2026/9/9
• 评级变动
  Craig-Hallum Maintains Guardant Health(GH.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• 评级变动
  Goldman Sachs Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $210
  \u5e02\u573a\u8d44\u8baf · 2026/9/9
• 评级变动
  Analysts Are Bullish on These Healthcare Stocks: Fractyl Health, Inc. (GUTS), Guardant Health (GH)
  TipRanks · 2026/9/2
• 公司公告
  HHRG-WB (HHRG BHD): Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - GH CONSORTIUM SDN BHD
  Bursa Malaysia · 2026/5/19
• 评级变动
  Wells Fargo Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $44
  \u5e02\u573a\u8d44\u8baf · 2026/8/31
• 评级变动
  H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $65
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• 评级变动
  CCORF Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39
  \u5e02\u573a\u8d44\u8baf · 2026/8/8

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。